Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: A RigiScan and pharmacokinetic study

World Journal of Urology

Volumn 19, Issue 1, 2001, Pages 32-39

  Klotz, T ^a   Sachse, R ^b   Heidrich, A ^a   Jockenhovel F ^c   Rohde, G ^b   Wensing, G ^b   Horstmann, R ^b   Engelmann, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BAYER AG   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE; VARDENAFIL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; IMPOTENCE; MALE; MIDDLE AGED; PENIS ERECTION; RANDOMIZED CONTROLLED TRIAL;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADOLESCENT; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; IMIDAZOLES; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; SULFONES; TRIAZINES;

EID: 0035258442     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450000168     Document Type: Article

References (20)

1. 1. Benêt AE, Rehman J, Holcomb RG, Melman A (1996) The correlation between the new RigiScan plus software and the final diagnosis in the evaluation of erectile dysfunction. J Urol 156: 1947-1950
2. Bischoff E, Schneider K (2000) A conscious rabbit model is able to demonstrate the efficacy of vardenafil and sildenafil on penile erection. Int J Impôt Res 12 [Suppl 3]: 65
3. Bischoff E, Niewoehner U, Haning H, Es Sayed M, Schenke T, Schlemmer KH (2000) Vardenafil a potent and selective inhibitor of phosphodiesterase type 5 increases cGMP in rabbit corpus cavernosum. Int J Impôt Res 12 [Suppl 3]: 65
4. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impôt Res 8: 47-52
5. Braun M, Klotz T, Reifenrath B, Wassmer G, Engelmann U (1998) "KEED" - erster deutschsprachig validierter Fragebogen zur Erfassung der männlichen sexuellen Funktion. Aktuelle Urol 29: 300- 305
6. Broderick GA (1998) Evidence based assessment of erectile dysfunction. Int J Impôt Res 10 [Suppl 2]: S64- 73
7. Gramkow J, Lendorf A. Zhu J, Meyhoff HH (1999) Transcutaneous nitroglycerine in the treatment of erectile dysfunction: a placebo controlled clinical trial. Int J Impôt Res 11: 35-39
8. Hatzichristou DG, Hatzimouratidis K, loannides E, Yannakoyorgos K, Dimitriadis G, Kalinderis A (1998) Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J Urol 159: 1921-1926
9. Heaton JP, Morales A, Adams MA, Johnston B, el-Rashidy R (1995) Recovery of erectile function by the oral administration of apomorphine. Urology 45: 200-206
10. KimSC, BangJH, Hyun JS, Seo KK (1998) Changes in erectile response to repeated audiovisual sexual stimulation. Eur Urol 33: 290-292
11. Licht MR, Lewis RW, Wollan PC, Harris CD (1995) Comparison of RigiScan and sleep laboratory nocturnal penile tumescence in the diagnosis of organic impotence. J Urol 154: 1740 1743
12. McMahon CG, Tourna K (1999) Predictive value of patient history and correlation of nocturnal penile tumescence, colour duplex Doppler ultrasonography and dynamic cavernosometry and cavernosography in the evaluation of erectile dysfunction. Int .1 Impôt Res 11: 47-51
13. Ogrinc FG, Linet OI (1995) Evaluation of real-time RigiScan monitoring in pharmacological erection. J Urol 154: 1356-1359
14. Rosen RC. Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49: 822-830
15. Sachse R, Stark S, Liedl T, Hensen J, Rohde G, Wensing G, Horstmann R, Schrott KM (submitted for publication) A randomised, placebo-controlled, double-blind cross-over trial on the effects of single oral doses of 20 and 40 mg vardenafil, a novel PDE5-inhibitor. on penile rigidity and tumescence in men with erectile dysfunction
16. Udelson D, Park K. Sadeghi-Najed H, Salimpour P. Krane RJ, Goldstein I (1999) Axial penile buckling forces vs Rigiscan
17. radial rigidity as a function of intracavernosal pressure: why Rigiscan does not predict functional erections in individual patients. Int J Impôt Res 11: 327 337
18. Vanderschueren D, Heyrman RM, Keogh EJ, Casey RW, Weiske WH, Ogrinc FG, Koning Gans de HJ (1995) A study in patients with erectile dysfunction comparing different formulations of prostaglandin El. Alprostadil Study Group. J Urol 154: 1744-1747
19. Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N (1998) Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: doubleblind, placebo controlled crossover study. J Urol 160: 389-393
20. Zimmern P. Leach GE, Yao J. Wolde-Tsadik G (1999) Criteria of Rigiscan normalcy in aged men. Prog Urol 9: 3744